SCHEMBL35943

SCHEMBL35943

Cc1ccc(N(S(=O)(=O)C(F)(F)F)S(=O)(=O)C(F)(F)F)nc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 2/20 0.36
CCR1 P32246 1/20 0.36
CCR5 P51681 1/20 0.36
CCR8 P51685 1/20 0.36
NOS3 P29474 1/20 0.34
NOS2 P35228 1/20 0.34
PTGS2 P35354 5/20 0.34
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA5A P35218 1/20 0.33
CA9 Q16790 1/20 0.33
KDM4E B2RXH2 7/20 0.33
ALDH1A1 P00352 4/20 0.33
GAA P10253 3/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 2/20 0.33
RAB9A P51151 3/20 0.33
PTGS1 P23219 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.31
NPC1 O15118 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL69571 0.79 NFE2L2 (0.36) HDAC6PTGS2KDM4EALDH1A1MAPT
SCHEMBL29377776 0.79 NFE2L2 (0.36) HDAC6PTGS2KDM4EALDH1A1MAPT
SCHEMBL4554960 0.79
SCHEMBL45935 0.79 DEGS1 (0.35) PTGS1
SCHEMBL14553395 0.76 KDM4E (0.34) KDM4EGAASMN1; SMN2LMNAHTT
SCHEMBL26504194 0.76 CCR6 (0.37) HDAC6KDM4EALDH1A1L3MBTL1
SCHEMBL15944537 0.74 NFE2L2 (0.33) HDAC6KDM4EALDH1A1HPGDHSD17B10
SCHEMBL15557360 0.72 ALDH1A1 (0.50) PTGS2KDM4EALDH1A1GAAMAPT
SCHEMBL2199940 0.72 CA9 (0.47) PTGS2CA1CA2CA5ACA9
SCHEMBL29443546 0.71 ALDH1A1 (0.41) HDAC6KDM4EALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8716267-B2 Bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators ALLERGAN, INC. (US) 2014-05-06 US disclosed
US-8178560-B2 Therapeutic agents useful for treating pain PURDUE PHARMA L.P. (US) 2012-05-15 US disclosed
US-20110281822-A1 AROMATIC COMPOUNDS HAVING SPHINGOSINE-1-PHOSPHONATE (S1P) RECEPTOR ACTIVITY ALLERGAN, INC. (US) 2011-11-17 US disclosed
US-20100331369-A1 Therapeutic Agents Useful for Treating Pain PURDUE PHARMA L.P. (US) 2010-12-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100331369-A1 Therapeutic Agents Useful for Treating Pain GRIN1, GRIK1, GRIN2B HDAC6 196/4885CCR1 717/4885CCR5 2855/4885
US-20110281822-A1 AROMATIC COMPOUNDS HAVING SPHINGOSINE-1-PHOSPHONATE (S1P) RECEPTOR ACTIVITY S1PR1, S1PR3, S1PR2 HDAC6 2794/4885CCR1 321/4885CCR5 435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.